Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1).
Hannah KönigA RommelJens BaumertChristian SchmidtHans-Helmut KönigChristian BrettschneiderAlexander KonnopkaPublished in: BMJ open (2021)
T2D was associated with high costs, mainly due to direct costs. As pointed out by our results, diabetes complications and comorbidities have a large impact on the costs, leaving medication costs as main contributor of T2D excess costs.